Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 75 | 2024 | 2585 | 15.540 |
Why?
|
Shock, Septic | 21 | 2024 | 769 | 5.120 |
Why?
|
Cross Infection | 21 | 2024 | 1422 | 3.880 |
Why?
|
Anti-Bacterial Agents | 35 | 2024 | 7407 | 2.600 |
Why?
|
Multiple Organ Failure | 6 | 2023 | 386 | 1.870 |
Why?
|
Hospital Mortality | 25 | 2024 | 5295 | 1.680 |
Why?
|
Infection Control | 12 | 2023 | 983 | 1.510 |
Why?
|
Community-Acquired Infections | 4 | 2024 | 469 | 1.470 |
Why?
|
Population Surveillance | 7 | 2024 | 2598 | 1.430 |
Why?
|
Hospitals | 25 | 2024 | 3881 | 1.370 |
Why?
|
Virus Diseases | 4 | 2024 | 716 | 1.300 |
Why?
|
Electronic Health Records | 11 | 2024 | 4822 | 1.160 |
Why?
|
Bacteremia | 6 | 2024 | 978 | 1.130 |
Why?
|
Fungemia | 2 | 2024 | 57 | 1.110 |
Why?
|
Pneumonia, Ventilator-Associated | 4 | 2023 | 279 | 1.060 |
Why?
|
Catheter-Related Infections | 5 | 2021 | 273 | 1.050 |
Why?
|
Hospitalization | 20 | 2024 | 10707 | 1.040 |
Why?
|
Aerosols | 4 | 2022 | 635 | 0.970 |
Why?
|
Quality Indicators, Health Care | 6 | 2024 | 1789 | 0.960 |
Why?
|
Critical Illness | 6 | 2023 | 2724 | 0.930 |
Why?
|
Respiratory Tract Infections | 5 | 2024 | 1009 | 0.920 |
Why?
|
Communicable Diseases | 3 | 2021 | 873 | 0.890 |
Why?
|
Burkholderia cepacia | 1 | 2022 | 22 | 0.840 |
Why?
|
Burkholderia cepacia complex | 1 | 2022 | 24 | 0.830 |
Why?
|
Burkholderia Infections | 1 | 2022 | 41 | 0.810 |
Why?
|
Humans | 152 | 2024 | 761222 | 0.800 |
Why?
|
Critical Care | 8 | 2023 | 2696 | 0.790 |
Why?
|
beta-Lactams | 1 | 2023 | 156 | 0.770 |
Why?
|
United States | 49 | 2024 | 72341 | 0.770 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2023 | 365 | 0.740 |
Why?
|
Emergency Service, Hospital | 11 | 2024 | 7865 | 0.730 |
Why?
|
Pandemics | 15 | 2023 | 8663 | 0.720 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2024 | 696 | 0.710 |
Why?
|
Clinical Coding | 3 | 2017 | 181 | 0.680 |
Why?
|
Surgical Wound Infection | 4 | 2022 | 1530 | 0.680 |
Why?
|
Quality Improvement | 7 | 2020 | 3808 | 0.620 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 5 | 2021 | 250 | 0.620 |
Why?
|
Pneumonia, Viral | 6 | 2021 | 3215 | 0.610 |
Why?
|
Lactic Acid | 3 | 2021 | 1139 | 0.610 |
Why?
|
Laboratories | 1 | 2021 | 462 | 0.590 |
Why?
|
Digestive System Surgical Procedures | 2 | 2022 | 571 | 0.570 |
Why?
|
Retrospective Studies | 45 | 2024 | 80675 | 0.570 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 826 | 0.560 |
Why?
|
Reimbursement, Incentive | 5 | 2024 | 542 | 0.540 |
Why?
|
Academic Medical Centers | 4 | 2022 | 2756 | 0.510 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3093 | 0.510 |
Why?
|
Medicare | 7 | 2024 | 6774 | 0.510 |
Why?
|
Anti-Infective Agents | 2 | 2020 | 983 | 0.500 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 561 | 0.490 |
Why?
|
Decision Support Systems, Clinical | 2 | 2022 | 1172 | 0.490 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2022 | 1462 | 0.470 |
Why?
|
Incidence | 17 | 2023 | 21366 | 0.460 |
Why?
|
Aged | 41 | 2024 | 169292 | 0.450 |
Why?
|
Severity of Illness Index | 10 | 2022 | 15841 | 0.440 |
Why?
|
Sentinel Surveillance | 1 | 2015 | 291 | 0.440 |
Why?
|
Masks | 4 | 2023 | 209 | 0.420 |
Why?
|
Patient Care Planning | 1 | 2018 | 901 | 0.420 |
Why?
|
Hospital Administration | 1 | 2016 | 352 | 0.410 |
Why?
|
Databases, Factual | 4 | 2018 | 7965 | 0.400 |
Why?
|
Critical Pathways | 1 | 2016 | 475 | 0.400 |
Why?
|
Adult | 45 | 2024 | 221120 | 0.390 |
Why?
|
Intensive Care Units | 8 | 2024 | 3744 | 0.370 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2017 | 668 | 0.360 |
Why?
|
Patient Care Management | 1 | 2014 | 303 | 0.360 |
Why?
|
West Nile Fever | 1 | 2011 | 75 | 0.360 |
Why?
|
West Nile virus | 1 | 2011 | 77 | 0.350 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2024 | 619 | 0.340 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2015 | 463 | 0.340 |
Why?
|
Urinary Tract Infections | 3 | 2022 | 801 | 0.340 |
Why?
|
Epidemiologic Methods | 1 | 2014 | 1336 | 0.330 |
Why?
|
Government Regulation | 1 | 2014 | 523 | 0.330 |
Why?
|
Middle Aged | 39 | 2024 | 220858 | 0.330 |
Why?
|
Data Collection | 2 | 2018 | 3320 | 0.330 |
Why?
|
Documentation | 1 | 2015 | 900 | 0.320 |
Why?
|
Staphylococcus aureus | 2 | 2017 | 1450 | 0.310 |
Why?
|
Male | 47 | 2024 | 360703 | 0.310 |
Why?
|
Viruses | 2 | 2024 | 372 | 0.310 |
Why?
|
Health Personnel | 5 | 2022 | 3337 | 0.310 |
Why?
|
Female | 48 | 2024 | 392552 | 0.300 |
Why?
|
Massachusetts | 9 | 2024 | 8837 | 0.300 |
Why?
|
Clinical Protocols | 1 | 2014 | 1436 | 0.300 |
Why?
|
Guideline Adherence | 1 | 2018 | 2220 | 0.300 |
Why?
|
Inappropriate Prescribing | 2 | 2020 | 212 | 0.290 |
Why?
|
Physicians | 3 | 2022 | 4584 | 0.290 |
Why?
|
Practice Guidelines as Topic | 6 | 2024 | 7400 | 0.280 |
Why?
|
Health Policy | 4 | 2021 | 2679 | 0.280 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1401 | 0.280 |
Why?
|
Fever | 1 | 2014 | 1618 | 0.270 |
Why?
|
Risk Adjustment | 2 | 2021 | 601 | 0.270 |
Why?
|
Medical Audit | 2 | 2018 | 452 | 0.270 |
Why?
|
Logistic Models | 5 | 2021 | 13249 | 0.260 |
Why?
|
Insurance, Health | 2 | 2015 | 2493 | 0.260 |
Why?
|
Delayed Diagnosis | 2 | 2020 | 465 | 0.260 |
Why?
|
Benchmarking | 2 | 2023 | 1045 | 0.250 |
Why?
|
Infectious Disease Medicine | 2 | 2016 | 49 | 0.250 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2021 | 585 | 0.250 |
Why?
|
Insurance Claim Reporting | 2 | 2017 | 165 | 0.250 |
Why?
|
Respiratory Syncytial Viruses | 2 | 2024 | 168 | 0.240 |
Why?
|
Exercise | 1 | 2021 | 5874 | 0.240 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12052 | 0.240 |
Why?
|
Cardiac Surgical Procedures | 2 | 2023 | 3627 | 0.230 |
Why?
|
Urinary Catheterization | 3 | 2020 | 193 | 0.230 |
Why?
|
Time Factors | 7 | 2024 | 39957 | 0.230 |
Why?
|
Metapneumovirus | 1 | 2024 | 28 | 0.230 |
Why?
|
Influenza, Human | 3 | 2024 | 1521 | 0.230 |
Why?
|
Paramyxoviridae Infections | 1 | 2024 | 57 | 0.220 |
Why?
|
Monobactams | 1 | 2023 | 16 | 0.220 |
Why?
|
Patient Isolators | 1 | 2023 | 11 | 0.220 |
Why?
|
Age Distribution | 2 | 2019 | 2871 | 0.220 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58952 | 0.220 |
Why?
|
Clostridium Infections | 2 | 2021 | 557 | 0.220 |
Why?
|
Aspergillus | 1 | 2023 | 94 | 0.210 |
Why?
|
Ralstonia pickettii | 1 | 2022 | 4 | 0.210 |
Why?
|
Early Diagnosis | 2 | 2020 | 1186 | 0.210 |
Why?
|
International Classification of Diseases | 4 | 2016 | 915 | 0.210 |
Why?
|
Water Purification | 1 | 2023 | 60 | 0.210 |
Why?
|
Delivery of Health Care | 6 | 2023 | 5333 | 0.210 |
Why?
|
Boston | 4 | 2021 | 9327 | 0.200 |
Why?
|
Tissue Donors | 2 | 2011 | 2335 | 0.200 |
Why?
|
Cohort Studies | 14 | 2024 | 41496 | 0.190 |
Why?
|
Prevalence | 6 | 2022 | 15721 | 0.190 |
Why?
|
Drug Contamination | 1 | 2022 | 151 | 0.190 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2023 | 149 | 0.190 |
Why?
|
Reproducibility of Results | 8 | 2023 | 20118 | 0.190 |
Why?
|
Length of Stay | 5 | 2024 | 6417 | 0.180 |
Why?
|
Visitors to Patients | 1 | 2020 | 36 | 0.180 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 33 | 0.180 |
Why?
|
Urinalysis | 1 | 2022 | 368 | 0.170 |
Why?
|
Occupational Exposure | 2 | 2021 | 1814 | 0.170 |
Why?
|
Pneumonia | 2 | 2023 | 2142 | 0.170 |
Why?
|
Calcitonin | 1 | 2021 | 329 | 0.170 |
Why?
|
Death Certificates | 1 | 2020 | 168 | 0.170 |
Why?
|
Quality Assurance, Health Care | 2 | 2021 | 2164 | 0.170 |
Why?
|
Water | 2 | 2022 | 1410 | 0.160 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.160 |
Why?
|
Catalysis | 1 | 2021 | 763 | 0.160 |
Why?
|
Liver Transplantation | 1 | 2011 | 2332 | 0.160 |
Why?
|
Propensity Score | 2 | 2024 | 1916 | 0.160 |
Why?
|
Infusions, Intravenous | 1 | 2023 | 2217 | 0.150 |
Why?
|
Mediastinitis | 1 | 2018 | 49 | 0.150 |
Why?
|
Pseudomonas Infections | 1 | 2022 | 621 | 0.150 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.150 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2023 | 624 | 0.150 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 746 | 0.150 |
Why?
|
Respiratory System | 1 | 2021 | 562 | 0.150 |
Why?
|
Disease Management | 2 | 2018 | 2507 | 0.150 |
Why?
|
Standard of Care | 1 | 2021 | 550 | 0.140 |
Why?
|
Treatment Outcome | 7 | 2023 | 64681 | 0.140 |
Why?
|
Allied Health Personnel | 1 | 2018 | 154 | 0.140 |
Why?
|
Pharmacoepidemiology | 1 | 2021 | 351 | 0.140 |
Why?
|
Lyme Disease | 1 | 2023 | 631 | 0.140 |
Why?
|
Catheters, Indwelling | 1 | 2019 | 426 | 0.140 |
Why?
|
Resuscitation | 1 | 2021 | 672 | 0.140 |
Why?
|
Risk Factors | 11 | 2024 | 74241 | 0.140 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2018 | 237 | 0.140 |
Why?
|
Fasciitis, Necrotizing | 1 | 2017 | 79 | 0.130 |
Why?
|
Disease Outbreaks | 2 | 2022 | 1747 | 0.130 |
Why?
|
Vancomycin | 1 | 2019 | 503 | 0.130 |
Why?
|
Hospitals, General | 1 | 2020 | 799 | 0.130 |
Why?
|
Dexamethasone | 1 | 2023 | 1945 | 0.120 |
Why?
|
Comorbidity | 5 | 2024 | 10516 | 0.120 |
Why?
|
Buprenorphine | 1 | 2023 | 656 | 0.120 |
Why?
|
Viral Load | 2 | 2022 | 3328 | 0.120 |
Why?
|
Shock | 1 | 2017 | 314 | 0.120 |
Why?
|
Neoplasms | 2 | 2021 | 22142 | 0.120 |
Why?
|
Current Procedural Terminology | 1 | 2015 | 89 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2022 | 2329 | 0.120 |
Why?
|
Suburethral Slings | 1 | 2015 | 72 | 0.120 |
Why?
|
Patient Admission | 1 | 2021 | 1365 | 0.110 |
Why?
|
Cost of Illness | 2 | 2023 | 1936 | 0.110 |
Why?
|
Laminectomy | 1 | 2015 | 225 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2021 | 1390 | 0.110 |
Why?
|
Checklist | 1 | 2020 | 828 | 0.110 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1331 | 0.100 |
Why?
|
Spinal Fusion | 1 | 2022 | 1294 | 0.100 |
Why?
|
Cholecystectomy | 1 | 2015 | 404 | 0.100 |
Why?
|
Hospitals, University | 1 | 2014 | 565 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1265 | 0.100 |
Why?
|
Registries | 2 | 2020 | 8246 | 0.100 |
Why?
|
Young Adult | 7 | 2021 | 59222 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1885 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2020 | 1490 | 0.100 |
Why?
|
Risk Assessment | 5 | 2021 | 24022 | 0.100 |
Why?
|
Motivation | 1 | 2021 | 2002 | 0.100 |
Why?
|
New York | 1 | 2014 | 875 | 0.100 |
Why?
|
Appendectomy | 1 | 2015 | 434 | 0.090 |
Why?
|
Vaccination | 1 | 2023 | 3369 | 0.090 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 590 | 0.090 |
Why?
|
Lymphatic Irradiation | 1 | 2010 | 115 | 0.090 |
Why?
|
Ventilators, Mechanical | 2 | 2022 | 288 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 2015 | 807 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3354 | 0.080 |
Why?
|
Antilymphocyte Serum | 1 | 2010 | 491 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5869 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2164 | 0.070 |
Why?
|
Public Health | 1 | 2021 | 2672 | 0.070 |
Why?
|
Medicine | 1 | 2015 | 942 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3239 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2021 | 4321 | 0.070 |
Why?
|
Respiration, Artificial | 3 | 2022 | 2631 | 0.070 |
Why?
|
Base Pair Mismatch | 1 | 2006 | 92 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2896 | 0.070 |
Why?
|
Communication | 1 | 2020 | 3872 | 0.060 |
Why?
|
Algorithms | 2 | 2023 | 14025 | 0.060 |
Why?
|
Patient Care Team | 1 | 2016 | 2515 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26072 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12474 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14675 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8002 | 0.060 |
Why?
|
Cytomegalovirus Infections | 1 | 2010 | 828 | 0.060 |
Why?
|
Odds Ratio | 3 | 2021 | 9652 | 0.060 |
Why?
|
Transplantation Conditioning | 1 | 2010 | 1591 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 2 | 2021 | 1936 | 0.050 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2006 | 484 | 0.050 |
Why?
|
Rhinovirus | 1 | 2024 | 203 | 0.050 |
Why?
|
Chlorhexidine | 1 | 2023 | 160 | 0.050 |
Why?
|
Ice | 1 | 2023 | 102 | 0.050 |
Why?
|
England | 1 | 2023 | 526 | 0.050 |
Why?
|
Southeastern United States | 1 | 2021 | 91 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 317 | 0.050 |
Why?
|
Ceftazidime | 1 | 2021 | 57 | 0.050 |
Why?
|
Ventilation | 1 | 2021 | 128 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7386 | 0.050 |
Why?
|
Azabicyclo Compounds | 1 | 2021 | 68 | 0.050 |
Why?
|
Hospital Bed Capacity | 1 | 2021 | 206 | 0.040 |
Why?
|
Adolescent | 4 | 2021 | 88300 | 0.040 |
Why?
|
Feedback | 1 | 2023 | 790 | 0.040 |
Why?
|
Adenoviridae | 1 | 2024 | 1084 | 0.040 |
Why?
|
Oxygen | 2 | 2023 | 4228 | 0.040 |
Why?
|
Personnel, Hospital | 1 | 2021 | 285 | 0.040 |
Why?
|
beta-Lactamases | 1 | 2021 | 304 | 0.040 |
Why?
|
Viral Proteins | 1 | 2006 | 1798 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 848 | 0.040 |
Why?
|
Opiate Substitution Treatment | 1 | 2023 | 444 | 0.040 |
Why?
|
Child | 3 | 2022 | 80154 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 130 | 0.040 |
Why?
|
Carbapenems | 1 | 2018 | 123 | 0.040 |
Why?
|
Infant | 1 | 2019 | 36170 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4190 | 0.040 |
Why?
|
Gram-Negative Bacteria | 1 | 2018 | 271 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 12940 | 0.030 |
Why?
|
Fluoroquinolones | 1 | 2018 | 307 | 0.030 |
Why?
|
Population Growth | 1 | 2016 | 50 | 0.030 |
Why?
|
Economics, Hospital | 1 | 2018 | 210 | 0.030 |
Why?
|
Culture Techniques | 1 | 2016 | 530 | 0.030 |
Why?
|
Thinness | 1 | 2019 | 481 | 0.030 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 526 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7512 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2022 | 1272 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2048 | 0.030 |
Why?
|
Streptococcus pyogenes | 1 | 2017 | 292 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2019 | 616 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3688 | 0.030 |
Why?
|
Drug Prescriptions | 1 | 2023 | 1668 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 845 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2020 | 1017 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2020 | 1048 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4921 | 0.030 |
Why?
|
Causality | 1 | 2019 | 1244 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2019 | 1472 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2016 | 655 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1878 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15637 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2016 | 645 | 0.020 |
Why?
|
California | 1 | 2016 | 1431 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2545 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2016 | 752 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4015 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10553 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3441 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2193 | 0.020 |
Why?
|
Transplantation | 1 | 2010 | 221 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4246 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29688 | 0.020 |
Why?
|
Viremia | 1 | 2010 | 707 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2018 | 1394 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54437 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12728 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 3805 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8457 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2010 | 989 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10088 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2010 | 750 | 0.020 |
Why?
|
Medicaid | 1 | 2018 | 2813 | 0.010 |
Why?
|
Leucine | 1 | 2006 | 546 | 0.010 |
Why?
|
Education, Medical | 1 | 2015 | 1725 | 0.010 |
Why?
|
Alanine | 1 | 2006 | 608 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22174 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15308 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4822 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18384 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13511 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1737 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12952 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26200 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2010 | 3048 | 0.010 |
Why?
|
Binding Sites | 1 | 2006 | 5988 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 5406 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5666 | 0.010 |
Why?
|